177 related articles for article (PubMed ID: 35434269)
21. The Hippo Pathway in Liver Homeostasis and Pathophysiology.
Driskill JH; Pan D
Annu Rev Pathol; 2021 Jan; 16():299-322. PubMed ID: 33234023
[TBL] [Abstract][Full Text] [Related]
22. Immuno-hippo: Research progress of the hippo pathway in autoimmune disease.
Guo P; Wang Z; Zhou Z; Tai Y; Zhang A; Wei W; Wang Q
Immunol Lett; 2021 Feb; 230():11-20. PubMed ID: 33345861
[TBL] [Abstract][Full Text] [Related]
23. A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis.
Azad T; Janse van Rensburg HJ; Lightbody ED; Neveu B; Champagne A; Ghaffari A; Kay VR; Hao Y; Shen H; Yeung B; Croy BA; Guan KL; Pouliot F; Zhang J; Nicol CJB; Yang X
Nat Commun; 2018 Mar; 9(1):1061. PubMed ID: 29535383
[TBL] [Abstract][Full Text] [Related]
24. The Hippo Pathway: Biology and Pathophysiology.
Ma S; Meng Z; Chen R; Guan KL
Annu Rev Biochem; 2019 Jun; 88():577-604. PubMed ID: 30566373
[TBL] [Abstract][Full Text] [Related]
25. The Hippo pathway is controlled by Angiotensin II signaling and its reactivation induces apoptosis in podocytes.
Wennmann DO; Vollenbröker B; Eckart AK; Bonse J; Erdmann F; Wolters DA; Schenk LK; Schulze U; Kremerskothen J; Weide T; Pavenstädt H
Cell Death Dis; 2014 Nov; 5(11):e1519. PubMed ID: 25393475
[TBL] [Abstract][Full Text] [Related]
26. The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration.
Wang J; Liu S; Heallen T; Martin JF
Nat Rev Cardiol; 2018 Nov; 15(11):672-684. PubMed ID: 30111784
[TBL] [Abstract][Full Text] [Related]
27. Identification of the kinase STK25 as an upstream activator of LATS signaling.
Lim S; Hermance N; Mudianto T; Mustaly HM; Mauricio IPM; Vittoria MA; Quinton RJ; Howell BW; Cornils H; Manning AL; Ganem NJ
Nat Commun; 2019 Apr; 10(1):1547. PubMed ID: 30948712
[TBL] [Abstract][Full Text] [Related]
28. The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis.
Zinatizadeh MR; Miri SR; Zarandi PK; Chalbatani GM; Rapôso C; Mirzaei HR; Akbari ME; Mahmoodzadeh H
Genes Dis; 2021 Jan; 8(1):48-60. PubMed ID: 33569513
[TBL] [Abstract][Full Text] [Related]
29. The Hippo pathway in cellular reprogramming and regeneration of different organs.
Moya IM; Halder G
Curr Opin Cell Biol; 2016 Dec; 43():62-68. PubMed ID: 27592171
[TBL] [Abstract][Full Text] [Related]
30. Hippo signaling in stress response and homeostasis maintenance.
Mao B; Gao Y; Bai Y; Yuan Z
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):2-9. PubMed ID: 25476206
[TBL] [Abstract][Full Text] [Related]
31. WW Domain-Containing Proteins YAP and TAZ in the Hippo Pathway as Key Regulators in Stemness Maintenance, Tissue Homeostasis, and Tumorigenesis.
Chen YA; Lu CY; Cheng TY; Pan SH; Chen HF; Chang NS
Front Oncol; 2019; 9():60. PubMed ID: 30805310
[TBL] [Abstract][Full Text] [Related]
32. Calcium, an Emerging Intracellular Messenger for the Hippo Pathway Regulation.
Wei Y; Li W
Front Cell Dev Biol; 2021; 9():694828. PubMed ID: 34268313
[TBL] [Abstract][Full Text] [Related]
33. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.
Zhao B; Li L; Lei Q; Guan KL
Genes Dev; 2010 May; 24(9):862-74. PubMed ID: 20439427
[TBL] [Abstract][Full Text] [Related]
34. Hippo Signaling in Embryogenesis and Development.
Wu Z; Guan KL
Trends Biochem Sci; 2021 Jan; 46(1):51-63. PubMed ID: 32928629
[TBL] [Abstract][Full Text] [Related]
35. Functions and regulations of the Hippo signaling pathway in intestinal homeostasis, regeneration and tumorigenesis.
Gu Y; Zhang L; Yu FX
Yi Chuan; 2017 Jul; 39(7):588-596. PubMed ID: 28757473
[TBL] [Abstract][Full Text] [Related]
36. MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway.
Lu J; Hu Z; Deng Y; Wu Q; Wu M; Song H
J Biol Chem; 2021; 296():100400. PubMed ID: 33571521
[TBL] [Abstract][Full Text] [Related]
37. The history and regulatory mechanism of the Hippo pathway.
Kim W; Jho EH
BMB Rep; 2018 Mar; 51(3):106-118. PubMed ID: 29397869
[TBL] [Abstract][Full Text] [Related]
38. A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas.
Deel MD; Li JJ; Crose LE; Linardic CM
Front Oncol; 2015; 5():190. PubMed ID: 26389076
[TBL] [Abstract][Full Text] [Related]
39. Arhgef7 promotes activation of the Hippo pathway core kinase Lats.
Heidary Arash E; Song KM; Song S; Shiban A; Attisano L
EMBO J; 2014 Dec; 33(24):2997-3011. PubMed ID: 25425573
[TBL] [Abstract][Full Text] [Related]
40. Identification of Cdk1-LATS-Pin1 as a Novel Signaling Axis in Anti-tubulin Drug Response of Cancer Cells.
Yeung B; Khanal P; Mehta V; Trinkle-Mulcahy L; Yang X
Mol Cancer Res; 2018 Jun; 16(6):1035-1045. PubMed ID: 29523761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
